产品详情
Targets
Target | Value |
---|---|
Bcl-2 | EC50:30.3nM |
Bcl-xL | EC50:78.7nM |
Bcl-w | EC50:197.8nM |
Bcl-B | EC50:1.82 uM |
Bfl-1 | EC50>10 uM |
Mcl-1 | EC50>10 uM |
In vitro (25°C) | DMSO | 92 mg/mL (113.1 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2%DMSO+40%PEG300+5%Tween80+53%ddH2O | 1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 12.29 mL | 61.47 mL | 122.94 mL |
0.5 mM | 2.46 mL | 12.29 mL | 24.59 mL |
1 mM | 1.23 mL | 6.15 mL | 12.29 mL |
5 mM | 0.25 mL | 1.23 mL | 2.46 mL |
*The above data is based on the productmolecular weight 813.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10255 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 813.4 |
Formula | C42H45ClN6O5S2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 852808-04-9 |
SMILES | CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-] |
产品标签
Product Questions
Product Questions
Bcl-2 Inhibitor
Bcl-2 Inhibitor包含两种互变异构体的混合物。一种有效的,细胞可渗透的Bcl-2抑制剂与Bak BH3肽竞争体外结合Bc…
ABT-492 (Delafloxacin)
ABT-492 (Delafloxacin)是一种新的氟喹诺酮类药物,可抵抗155种需氧和171种厌氧菌。
AT101 acetic acid
AT101 acetic acid对映体AT101与Bcl-2,Bcl-xL和Mcl-1结合,Ki分别为0.32μM,0.48μM和0.18μM;不抑制BIR3域和BID。
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
Sabutoclax
Sabutoclax (BI-97C1)是pan-Bcl-2抑制剂,包括Bcl-xL,Bcl-2,Mcl-1和Bfl-1,IC50分别为0.31 μM,0.32 μM,0.20 μM和0.62 μM。
Obatoclax mesylate (GX15-070)
Obatoclax Mesylate (GX15-070)是一种Bcl-2拮抗剂,拮抗所有抗凋亡Bcl-2家族蛋白(平均IC50,3 umol/L),包括Mcl-1(IC5…